Volume 11, Issue 6 | Applied Health Economics and Health Policy

Search all Applied Health Economics and Health Policy articles

Volume 11, Issue 6

December 2013

Filter by

Volume:

Sort by

Date published:

New to old Old to new

12 articles in this issue

Acknowledgement to Referees

Acknowledgement to Referees 13 November 2013 Pages: 559 - 560
An Overview of the Health Economic Implications of Elective Caesarean Section
Stavros Petrou
Kamran Khan
Review Article 24 October 2013 Pages: 561 - 576
The Economic Burden of Complications Occurring in Major Surgical Procedures: a Systematic Review
Ajay S. Patel
Annika Bergman
Ulf Haglund
Systematic Review 29 October 2013 Pages: 577 - 592
Cost-Effectiveness Analyses of Osteoarthritis Oral Therapies: a Systematic Review
Ronald C. Wielage
Julie A. Myers
Michael Happich
Systematic Review 09 November 2013 Pages: 593 - 618
Are the True Impacts of Adverse Events Considered in Economic Models of Antineoplastic Drugs? A Systematic Review
Alison Pearce
Marion Haas
Rosalie Viney
Systematic Review 16 October 2013 Pages: 619 - 637
Preferences on Policy Options for Ensuring the Financial Sustainability of Health Care Services in the Future: Results of a Stakeholder Survey
David Tordrup
Aris Angelis
Panos Kanavos
Original Research Article 16 October 2013 Pages: 639 - 652
Incremental Cost Effectiveness of Pharmacist-Managed Erythropoiesis-Stimulating Agent Clinics for Non-Dialysis-Dependent Chronic Kidney Disease Patients
Sherrie L. Aspinall
Kenneth J. Smith
Francesca E. Cunningham
Original Research Article 05 October 2013 Pages: 653 - 660
A Model-Based Economic Evaluation of Improved Primary Care Management of Patients with Type 2 Diabetes in Australia
Hossein Haji Ali Afzali
Jodi Gray
Jonathan Karnon
Original Research Article 16 November 2013 Pages: 661 - 670
Direct Medical Cost and Glycemic Control in Type 2 Diabetic Saudi Patients
Nora Almutairi
Khalid M. Alkharfy
Original Research Article 31 October 2013 Pages: 671 - 675
Impact of Delisting ARBs, Apart from Losartan, on ARB Utilisation Patterns in Denmark: Implications for Other Countries
Ulrik Hesse
Brian Godman
Rickard E. Malmström
Short Communication 09 October 2013 Pages: 677 - 685
Erratum to: Cost Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in Ireland
Dawn Lee
Patrick Thornton
Nic Brereton
Erratum 30 October 2013 Pages: 687 - 687
Erratum to: Cost Effectiveness of Paliperidone Palmitate for the Treatment of Schizophrenia in Germany
Jan Zeidler
Jörg Mahlich
Stephan Heres
Erratum 24 September 2013 Pages: 689 - 689